Health Condition 1: L404- Guttate psoriasis Health Condition 2: L408- Other psoriasis Health Condition 3: L400- Psoriasis vulgaris
Conditions
Interventions
None listed
Sponsors
VINOLYN DSOUZA
Eligibility
Inclusion criteria
Inclusion criteria: 1. All the patients with clinical diagnosis of psoriasis 2. Patients above the age of 12 years willing to participate in the study. 3. Patients who were on systemic treatment and had stopped 60 days prior to the study. 4. All age and sex matched healthy volunteers willing to participate in the study.
Exclusion criteria
Exclusion criteria: 1. Patients with Psoriasis –on systemic drugs like Methotrexate, Cyclosporine, Apremilast and Biologicals for the last 60 days. 2. Patients with a clinical diagnosis of palmoplantar and pustular psoriasis and acute febrile illness. 3. Patients with other pre-existing skin disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| This study will help to estimate the levels of an inflammatory cytokine (TNF a) and a chronic inflammatory marker (CRP) in psoriasis in an Indian population. This study will also determine whether these levels can be correlated with the disease severity.Timepoint: 18 months | — |
Secondary
| Measure | Time frame |
|---|---|
| The results will suggest the possible role of the markers in the etiopathogenesis and management of the disease.Timepoint: 18 months | — |
Countries
India
Contacts
Public ContactVINOLYN DSOUZA
FATHER MULLER MEDICAL COLLEGE HOSPITAL
Outcome results
None listed